Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
0.5332
-0.0067 (-1.24%)
At close: Oct 29, 2026, 4:00 PM EDT
0.5492
+0.0160 (3.00%)
Pre-market: Oct 30, 2026, 8:32 AM EDT
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $8.82 million as of October 29, 2026. It is the 42,131st most valuable company in the world and the 5,677th biggest in the United States. Its market cap has decreased by 81.76% in one year.
Market Cap
8.82M
Enterprise Value
15.60M
1-Year Change
-81.76%
Global Rank
Country Rank
#5,677 United States
Category
ChartMarket Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $8.82M, a decrease of -90.05%. That is a compound annual growth rate of -35.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 8.77M | -38.01% |
| Dec 31, 2025 | 14.14M | -61.17% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GT Biopharma | 9.94M |
| Lantern Pharma | 9.89M |
| Lisata Therapeutics | 9.55M |
| BioLineRx | 9.54M |
| Palatin Technologies | 9.54M |
| Actuate Therapeutics | 9.20M |
| Ensysce Biosciences | 8.80M |
| Theriva Biologics | 8.72M |